Predicting Translatable Drug Combinations for ADCs - A Pharma Partner Case Study

VeriSIM Life investigated for our client Debiopharm a novel drug combination strategy that combines ADCs with current therapies to enhance their effectiveness in reducing tumor burden. Our hybrid AI computational platform, BIOiSIM ®, ranked the predicted optimal combinations with regard to efficacy based on our multi-dimensional Translational Index™ technology.

[Download the Report
.pdf)